125 related articles for article (PubMed ID: 31703635)
21. PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China.
Ge H; Cao YY; Chen LQ; Wang YM; Chen ZF; Wen DG; Zhang XF; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(5):409-15. PubMed ID: 19125794
[TBL] [Abstract][Full Text] [Related]
22. Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma.
Lee JH; Chang KK; Yoon C; Tang LH; Strong VE; Yoon SS
Ann Surg; 2018 Jan; 267(1):105-113. PubMed ID: 27759618
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
24. ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers.
Zhou RM; Niu CX; Wang N; Chen ZF; Lei SE; Li Y
Arch Med Res; 2012 Jan; 43(1):67-74. PubMed ID: 22374244
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma.
Wang Z; Wang K; Dang Y; Ouyang X; Zhang F; Wang W; Wang L; Huang Q
World J Surg Oncol; 2018 Mar; 16(1):40. PubMed ID: 29499718
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China.
Guo W; Wang N; Wang YM; Li Y; Wen DG; Chen ZF; He YT; Zhang JH
World J Gastroenterol; 2005 Feb; 11(6):858-62. PubMed ID: 15682481
[TBL] [Abstract][Full Text] [Related]
27. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
[TBL] [Abstract][Full Text] [Related]
28. Investigating a pathogenic role for TXNDC5 in tumors.
Chang X; Xu B; Wang L; Wang Y; Wang Y; Yan S
Int J Oncol; 2013 Dec; 43(6):1871-84. PubMed ID: 24100949
[TBL] [Abstract][Full Text] [Related]
29. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
30. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
31. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma.
Zhang J; Cui Y; Kuang G; Li Y; Wang N; Wang R; Guo W; Wen D; Wei L; Yu F; Wang S
Carcinogenesis; 2004 Dec; 25(12):2479-85. PubMed ID: 15284183
[TBL] [Abstract][Full Text] [Related]
32. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
Althobiti M; El-Sharawy KA; Joseph C; Aleskandarany M; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Oct; 189(3):621-630. PubMed ID: 34453638
[TBL] [Abstract][Full Text] [Related]
33. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric Cancer.
Liu YP; Chen WD; Li WN; Zhang M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819869928. PubMed ID: 31530096
[TBL] [Abstract][Full Text] [Related]
35. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms.
Ohmori Y; Nomura T; Fukushima N; Takahashi F; Iwaya T; Koeda K; Nishizuka SS;
J Surg Oncol; 2019 Dec; 120(7):1154-1161. PubMed ID: 31578743
[TBL] [Abstract][Full Text] [Related]
36. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
37. Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis.
Yu D; Chen Y; Luo M; Peng Y; Yi S
Genet Res (Camb); 2022; 2022():1256021. PubMed ID: 36407082
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
39. Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer.
Sun B; Lin Y; Wang X; Lan F; Yu Y; Huang Q
Clin Lab; 2016 Nov; 62(11):2099-2105. PubMed ID: 28164661
[TBL] [Abstract][Full Text] [Related]
40. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
